Previous close | 6.02 |
Open | 6.00 |
Bid | 6.12 x 400 |
Ask | 6.18 x 400 |
Day's range | 5.97 - 6.34 |
52-week range | 4.74 - 9.59 |
Volume | |
Avg. volume | 1,401,727 |
Market cap | 2.349B |
Beta (5Y monthly) | 1.41 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of directors. Dr. DeLuca is a psychiatrist and accomplished physician executive with over 20 years of leadership experience, having held senior executive leadership roles at Magellan Health, Humana and Walgreens, and brings extensive healthcare operations and clinical management expertise to LifeStance's board of dir
SCOTTSDALE, Ariz., Feb. 28, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2023. (All results compared to prior-year comparative period, unless otherwise noted)2023 Highlights and 2024 Outlook Fourth quarter revenue of $280.6 million increased 22% and full year revenue of $1,055.7 million increased 23% compared to
SCOTTSDALE, Ariz., Feb. 07, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its fourth quarter and full year 2023 earnings release before the market opens on Wednesday, February 28, 2024. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 28, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871,